Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +33.33%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post earnings of $0.01 per share when it actually produced earnings of $0.01, delivering no surprise. ...

Wheaton Precious Metals Corp. (WPM) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Wheaton Precious Metals shares have added about 75.3% sinc ...

Core Insights - Eventbrite (EB) reported a quarterly loss of $0.02 per share, outperforming the Zacks Consensus Estimate of a loss of $0.08, marking a 75.00% earnings surprise [1] - The company generated revenues of $72.76 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 1.12%, but down from $84.55 million year-over-year [2] - Eventbrite has surpassed consensus EPS estimates three times over the last four quarters and topped revenue estimates four times in the same period [2] Financial Performance - The company's shares have declined approximately 26.8% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $74.71 million, and for the current fiscal year, it is -$0.27 on revenues of $299.43 million [7] Market Outlook - The Zacks Industry Rank places the Internet - Services sector in the bottom 37% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The company's Zacks Rank is currently 3 (Hold), suggesting that shares are expected to perform in line with the market in the near future [6]

Core Viewpoint - CarGurus reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.54 per share, and showing an increase from $0.41 per share a year ago, indicating a positive earnings surprise of +5.56% [1][2] Financial Performance - The company achieved revenues of $234.03 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.57%, and up from $218.69 million in the same quarter last year [2] - Over the last four quarters, CarGurus has consistently surpassed consensus EPS estimates four times and topped revenue estimates two times [2] Stock Performance and Outlook - CarGurus shares have declined approximately 13% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.55, with projected revenues of $238.67 million, and for the current fiscal year, the estimate is $2.15 on revenues of $938.78 million [7] - The estimate revisions trend for CarGurus was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Internet - Commerce industry, to which CarGurus belongs, is currently ranked in the bottom 34% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Insights - Figs (FIGS) reported quarterly earnings of $0.04 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, and showing a significant increase from $0.01 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company achieved revenues of $152.64 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.25% and reflecting a year-over-year increase from $144.23 million [2] - Figs has outperformed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] Earnings Outlook - The future performance of Figs' stock will largely depend on management's commentary during the earnings call and the revisions in earnings estimates [3][4] - The current consensus EPS estimate for the upcoming quarter is breakeven on revenues of $136.08 million, while for the current fiscal year, it is projected at $0.04 on revenues of $551.45 million [7] Industry Context - The Retail - Apparel and Shoes industry, to which Figs belongs, is currently ranked in the bottom 22% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Figs' stock performance [5][6]

Core Viewpoint - Applied Optoelectronics reported a quarterly loss of $0.16 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, but an improvement from a loss of $0.28 per share a year ago [1][2] Financial Performance - The company posted revenues of $102.95 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.83%, but showing significant growth from $43.27 million in the same quarter last year [3] - The earnings surprise for the quarter was -100.00%, with the company having surpassed consensus EPS estimates only once in the last four quarters [2] Stock Performance - Applied Optoelectronics shares have declined approximately 37% since the beginning of the year, contrasting with a 7.9% gain in the S&P 500 [4] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [7] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $118.77 million, and -$0.05 on revenues of $472.84 million for the current fiscal year [8] - The trend of estimate revisions for the company was mixed ahead of the earnings release, which could change following the recent report [7] Industry Context - The Electronics - Semiconductors industry, to which Applied Optoelectronics belongs, is currently ranked in the bottom 31% of over 250 Zacks industries, indicating potential challenges ahead [9]

Core Insights - Genpact reported quarterly earnings of $0.88 per share, exceeding the Zacks Consensus Estimate of $0.85 per share, and showing an increase from $0.79 per share a year ago, resulting in an earnings surprise of +3.53% [1] - The company achieved revenues of $1.25 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.92% and up from $1.18 billion year-over-year [2] - Genpact has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Genpact's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.88 on revenues of $1.25 billion, while for the current fiscal year, the estimate is $3.49 on revenues of $4.98 billion [7] Industry Context - The Computers - IT Services industry, to which Genpact belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5][6]

Financial Performance - PTC Therapeutics reported a quarterly loss of $0.83 per share, better than the Zacks Consensus Estimate of a loss of $1.07, and an improvement from a loss of $1.16 per share a year ago, representing an earnings surprise of +22.43% [1] - The company posted revenues of $178.88 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.82%, although this is a decrease from year-ago revenues of $186.7 million [2] - Over the last four quarters, PTC Therapeutics has exceeded consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - PTC Therapeutics shares have increased approximately 13.8% since the beginning of the year, outperforming the S&P 500's gain of 7.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$1.01 on revenues of $184.3 million, while for the current fiscal year, the estimate is $7.62 on revenues of $1.74 billion [7] - The outlook for the industry, specifically the Medical - Biomedical and Genetics sector, is favorable, ranking in the top 41% of over 250 Zacks industries, suggesting potential for outperformance [8]

Company Performance - GoDaddy reported quarterly earnings of $1.41 per share, exceeding the Zacks Consensus Estimate of $1.34 per share, and up from $1.1 per share a year ago, representing an earnings surprise of +5.22% [1] - The company posted revenues of $1.22 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.12%, and an increase from $1.12 billion year-over-year [2] - Over the last four quarters, GoDaddy has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - GoDaddy shares have declined approximately 21.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The current Zacks Rank for GoDaddy is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.47 on revenues of $1.23 billion, and for the current fiscal year, it is $5.92 on revenues of $4.9 billion [7] - The outlook for the Internet - Delivery Services industry, to which GoDaddy belongs, is currently in the top 12% of over 250 Zacks industries, suggesting a favorable environment for performance [8]

Core Viewpoint - Axon Enterprise (AXON) is experiencing solid improvements in earnings estimates, which may lead to continued short-term price momentum for the stock [1][2]. Estimate Revisions - The rising trend in estimate revisions reflects growing analyst optimism regarding Axon's earnings prospects, which is expected to positively impact its stock price [2]. - For the current quarter, Axon is projected to earn $1.54 per share, indicating a year-over-year increase of +6.2%. The Zacks Consensus Estimate has risen by 12% over the last 30 days, with no negative revisions [6]. - For the full year, the expected earnings per share is $6.44, representing a year-over-year change of +8.4%. The trend for current-year estimates is also positive, with two estimates moving higher and no negative revisions [7]. Zacks Rank - Axon has achieved a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, which is a reliable rating tool that helps investors capitalize on earnings estimate trends [8]. - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [8]. Stock Performance - Over the past four weeks, Axon shares have increased by 7.2%, indicating investor confidence in the company's earnings growth prospects [9].